ジャーナル・オブ・オンコロジーの研究と治療

抽象的な

Receptor-Interacting Serine/Threonine-Protein-Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer

Rola F. Jaafar1, Zeid Ibrahim1, Karim Ataya1, Joelle Hassanieh1, Natasha Ard2 and Walid G. Faraj

Receptor-interacting-serine/threonine-protein-kinase-2(RIPK2) is an important mediator in different pathways in the immune and inflammatory response system. RIPK2 was also shown to play different roles in different cancer types, however, in Colorectal Cancer(CRC); its role is not well established. This study aims at identifying the role of RIPK2 in CRC progression and survival.